These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 16565737)
1. High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy. Ueno NT; Konoplev S; Buchholz TA; Smith T; Rondón G; Anderlini P; Giralt SA; Gajewski JL; Donato ML; Cristofanilli M; Champlin RE Bone Marrow Transplant; 2006 May; 37(10):929-35. PubMed ID: 16565737 [TBL] [Abstract][Full Text] [Related]
2. The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy. Cheng YC; Rondón G; Yang Y; Smith TL; Gajewski JL; Donato ML; Shpall EJ; Jones R; Hortobagyi GN; Champlin RE; Ueno NT Biol Blood Marrow Transplant; 2004 Nov; 10(11):794-804. PubMed ID: 15505610 [TBL] [Abstract][Full Text] [Related]
3. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation. Demirer T; Uysal VA; Ayli M; Genc Y; Ilhan O; Koc H; Dagli M; Arat M; Gunel N; Fen T; Dincer S; Ustael N; Yildiz M; Ustun T; Seyrek E; Ozet G; Muftuoglu O; Akan H Bone Marrow Transplant; 2003 May; 31(9):755-61. PubMed ID: 12732881 [TBL] [Abstract][Full Text] [Related]
4. Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16. Crump M; Gluck S; Tu D; Stewart D; Levine M; Kirkbride P; Dancey J; O'Reilly S; Shore T; Couban S; Girouard C; Marlin S; Shepherd L; Pritchard KI J Clin Oncol; 2008 Jan; 26(1):37-43. PubMed ID: 18025439 [TBL] [Abstract][Full Text] [Related]
5. Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years. Hanrahan EO; Broglio K; Frye D; Buzdar AU; Theriault RL; Valero V; Booser DJ; Singletary SE; Strom EA; Gajewski JL; Champlin RE; Hortobagyi GN Cancer; 2006 Jun; 106(11):2327-36. PubMed ID: 16639731 [TBL] [Abstract][Full Text] [Related]
6. Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer. Schrama JG; Baars JW; Holtkamp MJ; Schornagel JH; Beijnen JH; Rodenhuis S Bone Marrow Transplant; 2001 Jul; 28(2):173-80. PubMed ID: 11509935 [TBL] [Abstract][Full Text] [Related]
7. Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13. Peters WP; Rosner GL; Vredenburgh JJ; Shpall EJ; Crump M; Richardson PG; Schuster MW; Marks LB; Cirrincione C; Norton L; Henderson IC; Schilsky RL; Hurd DD J Clin Oncol; 2005 Apr; 23(10):2191-200. PubMed ID: 15767638 [TBL] [Abstract][Full Text] [Related]
8. Comparison of double and triple high-dose chemotherapy with autologous blood stem cell transplantation in patients with metastatic breast cancer. Schneeweiss A; Hensel M; Goerner R; Khbeis T; Hohaus S; Egerer G; Solomayer E; Haas R; Grischke EM; Bastert G; Ho AD Stem Cells; 2001; 19(2):151-60. PubMed ID: 11239170 [TBL] [Abstract][Full Text] [Related]
9. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients. Kröger N; Damon L; Zander AR; Wandt H; Derigs G; Ferrante P; Demirer T; Rosti G; ; ; Bone Marrow Transplant; 2003 Dec; 32(12):1153-7. PubMed ID: 14647269 [TBL] [Abstract][Full Text] [Related]
10. High-dose chemotherapy with autologous stem cell rescue in women with metastatic breast cancer with involved bone marrow: a role for peripheral blood progenitor transplant. Myers SE; Mick R; Williams SF Bone Marrow Transplant; 1994 Apr; 13(4):449-54. PubMed ID: 8019470 [TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy, autologous bone marrow or stem cell transplantation and post-transplant consolidation chemotherapy in patients with advanced breast cancer. Tallman MS; Rademaker AW; Jahnke L; Brown SG; Bauman A; Mangan C; Kelly C; Rubin H; Kies MS; Shaw J; Kiel K; Gordon LI; Gradishar WJ; Winter JN Bone Marrow Transplant; 1997 Nov; 20(9):721-9. PubMed ID: 9384473 [TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant high dose chemotherapy plus peripheral blood progenitor cells in inflammatory breast cancer: a multicenter phase II pilot study. Dazzi C; Cariello A; Rosti G; Tienghi A; Molino A; Sabbatini R; Aieta M; Frassineti GL; Vertogen B; Giovanis P; Marangolo M Haematologica; 2001 May; 86(5):523-9. PubMed ID: 11410417 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of high-dose chemotherapy and autologous stem cell transplant in isolated locally recurrent breast cancer: a multicenter evaluation. Vij R; DiPersio J; Brown R; Trinkaus K; Abboud C; Meehan KR; Frenette G; Freytes C; Goodnough LT; Khoury H; Ponnuri J; Adkins D Bone Marrow Transplant; 2000 Nov; 26(9):947-53. PubMed ID: 11100273 [TBL] [Abstract][Full Text] [Related]
14. Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor? Banna GL; De Giorgi U; Ferrari B; Castagna L; Alloisio M; Marangolo M; Rosti G; Santoro A Biol Blood Marrow Transplant; 2006 Oct; 12(10):1085-91. PubMed ID: 17084372 [TBL] [Abstract][Full Text] [Related]
15. Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients. Stemmer SM; Hardan I; Raz H; Adamou AK; Inbar M; Gottfried M; Merrick Y; Cohen Y; Sulkes A; Ben-Baruch N; Pfeffer RP; Brenner HJ; Rizel S Bone Marrow Transplant; 2003 Apr; 31(8):655-61. PubMed ID: 12692605 [TBL] [Abstract][Full Text] [Related]
16. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study]. Shi Y; Pan F; Han X Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):890-3. PubMed ID: 11715500 [TBL] [Abstract][Full Text] [Related]
17. Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. Schetelig J; Fetscher S; Reichle A; Berdel WE; Beguin Y; Brunet S; Caballero D; Majolino I; Hagberg H; Johnsen HE; Kimby E; Montserrat E; Stewart D; Copplestone A; Rösler W; Pavel J; Kingreen D; Siegert W Haematologica; 2003 Nov; 88(11):1272-8. PubMed ID: 14607756 [TBL] [Abstract][Full Text] [Related]
18. Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot study. Stemmler HJ; Salat C; Lindhofer H; Menzel H; Untch M; Kahlert S; Konecny G; Sauer H; Ledderose G; Heinemann V; Kolb HJ Anticancer Res; 2005; 25(4):3047-54. PubMed ID: 16080564 [TBL] [Abstract][Full Text] [Related]
19. Randomized trial of single compared with tandem high-dose chemotherapy followed by autologous stem-cell transplantation in patients with chemotherapy-sensitive metastatic breast cancer. Kröger N; Frick M; Gluz O; Mohrmann S; Metzner B; Jackisch C; Ko Y; Lindemann HW; Meier CR; Lohrmann HP; Ruffert U; Hänel M; Bodenstein H; Neubauer A; Ehninger G; Wolf HH; Kolbe K; Burock K; Zander AR; Nitz U J Clin Oncol; 2006 Aug; 24(24):3919-26. PubMed ID: 16921043 [TBL] [Abstract][Full Text] [Related]
20. High-dose chemotherapy with autologous stem cell rescue in stage IIIB inflammatory breast cancer. Yalamanchili K; Lalmuanpuii J; Waheed F; Farjami S; Kancherla R; Qureshi Z; Hoang A; Khaled Y; Lake D; Puccio C; Chun HG; Seiter K; Ahmed T Anticancer Res; 2008; 28(5B):3139-42. PubMed ID: 19031971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]